Detalhe da pesquisa
1.
Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.
Immunity
; 42(4): 767-77, 2015 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25888260
2.
Monocytes promote UV-induced epidermal carcinogenesis.
Eur J Immunol
; 51(7): 1799-1808, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33759186
3.
The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.
Eur J Immunol
; 40(6): 1603-16, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20306469
4.
CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer.
Nat Commun
; 12(1): 769, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536445
5.
Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
Cell Rep
; 29(5): 1236-1248.e7, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665636
6.
Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
Cytometry A
; 73(11): 1010-8, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18612991
7.
WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
Oncogene
; 37(27): 3753-3762, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29662191
8.
CSF1R-dependent myeloid cells are required for NKmediated control of metastasis.
JCI Insight
; 3(10)2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769439
9.
Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.
Clin Cancer Res
; 24(24): 6345-6354, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154226
10.
Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
BMC Immunol
; 6: 24, 2005 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16329759
11.
Aldara activates TLR7-independent immune defence.
Nat Commun
; 4: 1560, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23463003
12.
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.
Oncoimmunology
; 2(3): e23562, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23687622
13.
Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways.
J Biol Chem
; 279(40): 42026-40, 2004 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15292163